New products are an essential part of the long-term strategy of every pharmaceutical company, and following the correct API selection process is an aspect that can save you time and money. On the contrary, the wrong choice can doom the whole developmental project!

Large companies typically have internal sourcing expertise but mid/ small-size companies often rely on external resources. API Solutions by QUINTA-ANALYTICA is a unique and truly independent consultancy concept without the distraction of heavy marketing campaigns or pressure from existing suppliers.

Our dedicated in-house API sourcing team, headed by Pavel Pihera keeps their finger on the pulse of the current global market landscape and in turn, offers their first-class sourcing expertise based on solid fundamentals and molecule-specific market intelligence that’s highly valuable for your development process.

Combining market research with analysis of real data, the team is able to assess supply reliability, regulatory and GMP-compliance, along with reviewing active substance master files obtained from API manufacturers, and/or a dedicated GMP-audit performed on-site by our certified QA internal teams.

Simply put, our API Solutions truly remove complexity and bring true value to your developmental process.

Additional News

  • 17 December 2025

    PF 2026: Thank You from Quinta-Analytica

    In 2025, Quinta-Analytica continued to turn complex development challenges into tangible progress. Our PF 2026 message looks back at key milestones and thanks the partners, clients, and teams who made them possible.

  • 15 December 2025

    IVBE for locally acting drugs: insights from Conscio Science Day in Munich

    Can bioequivalence for locally acting drugs be demonstrated without a single subject in a clinical trial? Yes, if your in vitro bioequivalence (IVBE) toolkit is set up in the right way.

  • 20 November 2025

    Webinar: Streamlined Evidence Strategies for Biosimilars: Analytics, PK and Immunogenicity in focus

    On behalf of Conscio Group, we are pleased to invite you to the upcoming free educational webinar from biosimilar series.